Filing Details
- Accession Number:
- 0001570523-18-000003
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-28 18:25:42
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-28 18:25:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-05 | 100 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-09 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-09 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-13 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-13 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-17 | 300 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-17 | 300 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-18 | 200 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-20 | 500 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-20 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-23 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-24 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-25 | 1,250 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-25 | 4,750 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-25 | 200 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-27 | 100 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-27 | 500 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-27 | 300 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-30 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-30 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-30 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-30 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-31 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-06 | 10,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-08 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-10 | 1,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-10 | 500 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-24 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-24 | 200 | $0.05 | 22,059,859 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
